Purchase Order 75N95022P00701

Award Date 9/20/22
Potential Completion Date 11/15/22
Potential Value $129K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marshallton, DE 19808, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $139,313 firm-fixed-price federal contract award was made by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Agilent Technologies Inc.'s Customer Service and Sales Division. The award is for the purchase of a high-throughput cell analysis system and automated incubator to support NIDA's NeuroTherapeutics Development Unit in screening and evaluating toxicities to neurons and other cells. The system has capabilities equivalent to the...
This is a $60,701.56 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The award was made to Agilent Technologies Inc., a manufacturer of scientific instruments and equipment. The contract has no set-aside designation. The award is for the provision of unspecified products and services by Agilent's Customer Service and Sales Division. Agilent is a major supplier of analytical...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed-price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for an automated liquid handling platform. The potential value of the contract is $150,380.10, and the period of performance ends on October 31, 2019. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing laboratories...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price purchase order to Agilent Technologies Inc.'s Customer Service And Sales Division for one Agilent BioTek Cytation 5 Cell Imaging Multimode Reader (or equivalent) for $79,999.99. The purchase order was awarded on October 11, 2023 with a period of performance from October 11, 2023 through October 10, 2024 to fulfill a requirement posted on August 3, 2023 seeking...
This federal contract award is for $149,639.77 and was issued by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets. The contract is for the purchase of scientific instruments, equipment, and services to support research at the agency. The contract does not have a set-aside designation and is a firm-fixed-price purchase order with a...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Agilent Technologies Inc. Customer Service And Sales Division. The contract has a ceiling value of $25,831.40 and is a Firm Fixed Price Purchase Order. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. The award is not associated with a larger contract vehicle. However, Agilent Technologies, Inc., the parent company of the...
The National Institute on Drug Abuse (NIDA) awarded a $120,384.00 firm-fixed-price purchase order to Agilent Technologies Inc. to provide preventative maintenance and on-call repair services for NIDA's Varian/Agilent MR400 Nuclear Magnetic Resonance Spectrometer (NMR). The contract has a base period of 12 months and two 12-month option periods. NIDA determined that Agilent is the only reasonably available source to provide these specialized services, as they are the exclusive service provider...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Agilent Technologies Inc. Customer Service and Sales Division for $151,086.60. The contract is for preventative maintenance and on-call repair services for NIDA's Agilent MR-400 nuclear magnetic resonance (NMR) spectrometer over a 5-year period from September 24, 2019 to September 23, 2024. The contract includes one...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a delivery order contract to Agilent Technologies Inc. for the purchase of a 1260 Infinity II Multisampler, a high-performance liquid chromatography instrument that can handle well plates and individual sample containers. The $25,008.97 firm-fixed-price contract was placed against Agilent's General Services Administration Federal Supply Schedule 66 for Scientific Equipment and...
The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a firm fixed-price purchase order valued at $99,500.00 to Certified Scientific Instrument, Inc. for the acquisition of used equipment. The requirement was a competitive solicitation with no set-aside designation. The contract includes three (3) Beckman Coulter BioRapTR microfluidic workstations and one (1) Perkin Elmer ViewLux ultraHTS Multilabel Reader with Stacker. The items are to be delivered within 30 days of the...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a $128,606.64 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division to provide a multimodal microplate reader with a plate stacker, known as the Synergy Neo2 or equal. This equipment is required by NIDA's Molecular Mechanisms of Cellular Stress and Inflammation (MMCSI) program to efficiently analyze various cell-based assays and RNA concentrations at high volume for studying the role of endoplasmic reticulum stress and inflammation in neuronal dysfunction. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, and has provided a wide range of scientific instruments and services to various federal agencies through prime and subcontracts. The contract has no set-aside designation, and the period of performance ends on November 15, 2022.

Generated 3/22/24, 12:22 AM